NCT05803941View on ClinicalTrials.gov

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

PHASE4RecruitingINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

July 20, 2033

Study Completion Date

July 21, 2033

Conditions

Prostate Cancer

Interventions

DRUG

AAA617

Long-term follow-up (LTFU) safety study of adult participants with prostate cancer that have received at least one dose of AAA617 from parent interventional Novartis sponsored clinical trials.

Trial Locations (54)

1090

RECRUITING

Novartis Investigative Site, Vienna

4020

RECRUITING

Novartis Investigative Site, Linz

9000

RECRUITING

Novartis Investigative Site, Ghent

10467

RECRUITING

Montefiore Medical Center, The Bronx

15232

RECRUITING

Univ of Pittsburgh Medical Center, Pittsburgh

17176

RECRUITING

Novartis Investigative Site, Stockholm

18057

RECRUITING

Novartis Investigative Site, Rostock

20422

RECRUITING

VA Medical Center, Washington D.C.

24014

RECRUITING

Onco Hemato Asso of SE Virginia, Roanoke

27710

RECRUITING

Duke University Medical Center, Durham

28034

RECRUITING

Novartis Investigative Site, Madrid

28040

RECRUITING

Novartis Investigative Site, Madrid

28041

RECRUITING

Novartis Investigative Site, Madrid

28046

RECRUITING

Novartis Investigative Site, Madrid

28222

RECRUITING

Novartis Investigative Site, Madrid

30607

RECRUITING

University Cancer and Blood Center LLC, Athens

32224

RECRUITING

Mayo Clinic Jacksonville, Jacksonville

39216

RECRUITING

University of Mississippi Med Ctr, Jackson

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

45147

RECRUITING

Novartis Investigative Site, Essen

46026

RECRUITING

Novartis Investigative Site, Valencia

46845

RECRUITING

Parkview Research Center, Fort Wayne

55905

RECRUITING

Mayo Clinic Rochester, Rochester

63110

RECRUITING

Wash U School of Medicine, St Louis

68130

RECRUITING

Urology Cancer Center PC, Omaha

68154

RECRUITING

Nebraska Cancer Specialists, Omaha

69373

RECRUITING

Novartis Investigative Site, Lyon

70112

RECRUITING

Tulane Cancer Center, New Orleans

70121

RECRUITING

Ochsner Clinic Foundation, New Orleans

77030

RECRUITING

UT Health Science Center, Houston

80045

RECRUITING

University of Colorado, Aurora

80377

RECRUITING

Novartis Investigative Site, München

85259

RECRUITING

Mayo Clinic Arizona, Scottsdale

90404

RECRUITING

Providence Saint Johns Health Ctr, Santa Monica

92686

RECRUITING

St. Joseph Hospital, Orange

06102

RECRUITING

Hartford Hospital, Hartford

48073-6769

RECRUITING

Corewell Health William Beaum Hosp, Royal Oak

75390-9034

RECRUITING

Univ of Texas Southwest Med Center, Dallas

H2X 1R9

RECRUITING

Novartis Investigative Site, Montreal

779 00

RECRUITING

Novartis Investigative Site, Olomouc

150 06

RECRUITING

Novartis Investigative Site, Prague

2625 AD

RECRUITING

Novartis Investigative Site, Delft

6229 HX

RECRUITING

Novartis Investigative Site, Maastricht

6500HB

RECRUITING

Novartis Investigative Site, Nijmegen

08208

RECRUITING

Novartis Investigative Site, Sabadell

08035

RECRUITING

Novartis Investigative Site, Barcelona

08036

RECRUITING

Novartis Investigative Site, Barcelona

08907

RECRUITING

Novartis Investigative Site, L'Hospitalet de Llobregat

413 45

RECRUITING

Novartis Investigative Site, Gothenburg

SM2 5PT

RECRUITING

Novartis Investigative Site, Sutton

EN5 3DJ

RECRUITING

Novartis Investigative Site, Barnet

CB2 0QQ

RECRUITING

Novartis Investigative Site, Cambridge

G12 0YN

RECRUITING

Novartis Investigative Site, Glasgow

TS4 3BW

RECRUITING

Novartis Investigative Site, Middlesbrough

Sponsors

Lead Sponsor

Novartis Pharmaceuticals

All Listed Sponsors

lead

Novartis Pharmaceuticals

INDUSTRY